fda compounding semaglutide update today Hims & Hers stock falls 25% as curtails compounded GLP-1s FDA issues warning about some

Without coverage (TFL, direct care): $299-$449/month via LillyDirect, ~$346/month via TrumpRx.gov, or ~$149/month for Foundayo (oral GLP-1)

The lack of a placebo control group made it impossible to tease out placebo effects from treatment effects

Report any suspected side effects to the MHRA Yellow Card Scheme

They have not been evaluated by the FDA for safety, effectiveness, or quality as finished products

If youre struggling with weight loss and are considering trying semaglutide, I encourage you to consult with your healthcare professional to determine if its the right choice for you

[PMC free article: PMC2879499] [PubMed: 20228404] 669